Your address will show here +12 34 56 78

 

SAN JUAN, PUERTO RICO, July 24, 2020 (GLOBE NEWSWIRE) – BOTS, Inc. (OTC: BTZI) (EXCHANGE: M06.SG), an emerging innovator of products, technologies, and services for the rapidly growing digital robotic automation and manufacturing industry announced today that it is in the process of repurposing and renaming FIRST BITCOIN (COIN:BIT) into the “Basic Income Token” while retaining “BIT” as the digital currency’s symbol.

There is a growing demand for a socialistic Universal Basic Income scheme in the United State of America heralded by former presidential candidate Andrew Yang, however, our capitalistic concept is to deliver an asset to our shareholders that produces income simply by keeping their wallets opened. The more wallets that remain open, the more secure the cryptocurrency becomes. This “income” will self-generate BITs 24/7 via Proof of Stake Mining (POS) protocol. Once we have hundreds of our 10s of thousands of shareholders keeping their wallets open, the blockchain becomes exceptionally secure.

Bots, Inc. and First Bitcoin Capital (OTC:BITCF) are working closely together to ensure a seamless transition of this major asset consisting of billions of BITs. Once the name of BIT is changed to Basic Income Token, Bots Inc. intends to distribute 1 BIT for each share of Bots Inc. to be held on a record date to be set for distribution as soon as August 30, 2020.

This asset is only one cryptocurrency of a larger inventory of more than 100 unique digital cryptocurrencies acquired from and previously owned by First Bitcoin Capital Corp. The most significant of the transferences of these cryptocurrencies to Bots Inc., included, but was not limited to, the majority ownership of First Bitcoin (COIN:BIT), a cryptocurrency based on a unique blockchain similar to an improved version of Litecoin, This coin trades on Livecoin.net with BIT included on the premier website for tracking of cryptocurrencies via https://coinmarketcap.com/currencies/first-bitcoin/   

Additionally BOTS, Inc. in conjunction with First Bitcoin Capital  has generated managed units of a newly minted cryptocurrency based on Bitcoin’s blockchain utilizing the Omni protocols also used by Tether (COIN:USDT) in an effort to alternatively fulfill Yang’s vision, defined as follows:

“Universal Basic Income (COIN:UBI) commemorates the presidential candidate Andrew Yang’s plan for distributing $1000 per month per citizen so that each world citizen is entitled to 1000 UBI per month upon request from Bots, Inc.”

“Those whom request this monthly UBI distribution will be required to cover Bots’ nominal Bitcoin transference costs and both Bots and First Bitcoin Capital will share in a 1% transference fee to be earned in kind. We will develop unique bots that will handle the inclusion of each requesting world- citizen wishing to use our automation in order to handle the sign ups and transfers” stated newly elected Company Chairman, Simon Rubin.

The creation of “UBI” which is under the management of Bots Inc and First Bitcoin Capital can be witnessed here:

https://omniexplorer.info/asset/829

About First Bitcoin Capital Corp

 

First Bitcoin Capital Corp (OTC:BITCF) is the largest shareholder of Bots, Inc. as a result of exchanging the majority of its assets therefor, but began developing digital currencies, proprietary blockchain technologies, and the digital currency exchange – www.CoinQX.com (in Beta) in early 2014. We saw this step as a tremendous opportunity to create further shareholder value by leveraging management’s experience in developing and managing complex blockchain technologies and in developing new types of digital assets. Being the first publicly-traded cryptocurrency and blockchain-centered company, we provide our shareholders with diversified exposure to digital cryptocurrencies and blockchain technologies.

The Company began developing its own blockchain and cryptocurrency called First Bitcoin (COIN:BIT) in 2016. Prior to transferring the majority of this asset to Bots, Inc., the Company updated the BIT wallet and added more functionality. Users are able to generate BIT through the processes of POW and POS mining. The First Bitcoin (COIN:BIT) cryptocurrency has a current supply of 20,707,629,255 BIT. It is currently trading on LIVECOIN.net with its explorer at www.explorer.bitcf.net.

 

https://coinmarketcap.com/currencies/first-bitcoin/

 

Contact us via: info@firstbitcoin.io or visit www.firstbitcoin.io

 

follow us on Twitter; @1stBitCapital

 

follow us on Linkedin: https://www.linkedin.com/company/first-bitcoin-capital-corp/

 

follow us on FaceBook: https://www.facebook.com/BITCF/

 

About BOTS, Inc.

Headquartered in San Juan, Puerto Rico, BOTS, Inc. – publicly traded on the OTC Markets under the symbol (BTZI) and on Börse Stuttgart under ticker (M06.SG) – is a diversified company developing and servicing blockchain solutions and robotics for its clientele. The Company is committed to drive the innovations needed to shape the future of digital robotic automation management through digital technology and decentralized blockchain solutions. Management is dedicated to the strong growth of Distributed Asset Technology and Robotic Process Automation (RPA).

Bots, Inc. has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit http://www.bots.bz

Visit us on Facebook @ https://www.facebook.com/Bots.Bz/

Follow us on Twitter @Bots_bz

 

 

Forward-Looking Statements

 

Certain statements contained in this press release may constitute “forward-looking statements.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as may be disclosed in company’s filings. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release. Such forward-looking statements are risks that are detailed in the Company’s website and filings.

 

Contact:

Paul Rosenberg

CEO

paul@bots.bz

0

San Juan, PUERTO RICO, July 22, 2020 (GLOBE NEWSWIRE) — BOTS, Inc. (OTC: BTZI) (GERMAN EXCHANGE: M06.SG) an emerging innovator of products, technologies, and services for the rapidly growing digital robotic automation and manufacturing industry is proud to announce that it has joined the Open Invention Network (OIN), the largest patent non-aggression community in history. Bots Inc has become a licensee and member of the 3,200 strong community of OIN licensees. As a leading provider of robotic and blockchain technology and infrastructure, BTZI is committed to embrace open source software (OSS). The company has acquired Bitcoin ATM patent and other patent pending from First Bitcoin Capital Corp (OTC : BITCF) and is planning to develop Global Bitcoin ATM network utilizing open source software platform as a Joint Venture with First Bitcoin Capital.

“In addition to being actively involved in blockchain and robotic automation development, Bots, Inc. is consistently monitoring the trends in this rapidly evolving industry,” said Paul Rosenberg, Company’s CEO. “By joining the Open Invention Network community, BTZI is further demonstrating its support for developing open source software.” “By joining the Open Invention Network, we show our continued commitment to innovation, and support for patent non-aggression in open source projects.”

 

About Open Invention Network

Open Invention Network (OIN) is the largest patent non-aggression community in history and supports freedom of action in Linux as a key element of open source software (OSS). Patent non-aggression in core technologies is a cultural norm within OSS, so that the litmus test for authentic behavior in the OSS community includes OIN membership. Funded by Google, IBM, NEC, Philips, Sony, SUSE and Toyota, OIN has more than 3,200 community members and owns more than 1,300 global patents and applications. The OIN patent license and member cross-licenses are available royalty-free to any party that joins the OIN community.

Open to all, OIN’s community practices patent non-aggression in core Linux and adjacent open source technologies by cross-licensing Linux System patents to one another on a royalty-free basis. Patents owned by Open Invention Network are similarly licensed royalty-free to any organization that agrees not to assert its patents against the Linux System. The OIN license can be signed online at http://www.j-oin.net/.

For more information, visit www.openinventionnetwork.com.

 

 

About BOTS, Inc.

Headquartered in San Juan, Puerto Rico, BOTS, Inc. – publicly traded on the OTC Markets under the symbol (BTZI) and on Börse Stuttgart under ticker (M06.SG) – is a diversified company developing and servicing blockchain solutions and robotics for its clientele. The Company is committed to drive the innovations needed to shape the future of digital robotic automation management through digital technology and decentralized blockchain solutions. Management is dedicated to the strong growth of Distributed Asset Technology and Robotic Process Automation (RPA).

Bots, Inc. has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit http://www.bots.bz

Visit us on Facebook @ https://www.facebook.com/Bots.Bz/

Follow us on Twitter @Bots_bz


About First Bitcoin Capital Corp

First Bitcoin Capital Corp (OTC:BITCF) began developing digital currencies, proprietary blockchain technologies, and the digital currency exchange – www.CoinQX.com (in Beta) in early 2014. We saw this step as a tremendous opportunity to create further shareholder value by leveraging management’s experience in developing and managing complex blockchain technologies and in developing new types of digital assets. Being the first publicly-traded cryptocurrency and blockchain-centered company, we provide our shareholders with diversified exposure to digital cryptocurrencies and blockchain technologies.

BITCF also owns patent U.S. Patent No. 9,135,787 – “Bitcoin Kiosk / ATM Device and System Integrating Enrollment Protocol and Method of Using the Same.” Known as the “Bitcoin ATM patent” this patent is related to the purchase and sale of cryptocurrencies utilizing a Bitcoin ATM or kiosk that allows customers to purchase Bitcoin or other cryptocurrencies by using cash, debit or credit cards.

The Company began developing its own blockchain and cryptocurrency called First Bitcoin (COIN:BIT) in 2016. Recently the Company updated the BIT wallet and added more functionality. Users are able to generate BIT through the processes of POW and POS mining. The First Bitcoin cryptocurrency has a current supply of 20,707,629,255 BIT. It is currently trading on LIVECOIN.net with its explorer at www.explorer.bitcf.net

https://coinmarketcap.com/currencies/first-bitcoin/

 

Contact us via: info@firstbitcoin.io or visit www.firstbitcoin.io

follow us on Twitter; @1stBitCapital

follow us on Linkedin: https://www.linkedin.com/company/first-bitcoin-capital-corp/

follow us on FaceBook: https://www.facebook.com/BITCF/

 

Forward-Looking Statements

 

Certain statements contained in this press release may constitute “forward-looking statements.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as may be disclosed in company’s filings. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release. Such forward-looking statements are risks that are detailed in the Company’s website and filings.

 

Contact:

Paul Rosenberg

CEO

paul@bots.bz

0

JACKSONVILLE, FL, July,9 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BOTS, Inc. formerly known as mCIG,Inc. (MCIG) (GERMAN EXCHANGE: M06.SG), emerging innovator of products, technologies, and services for the rapidly growing robotics industry – announced today that the Financial Industry Regulatory Authority (“FINRA”), has approved a change in the Company’s stock symbol on the OTC Markets. Effective July 9, 2020, the Company’s common shares will begin trading on the OTC Markets under the symbol “BTSS”. The previous trading symbol was “MCIG”.

There is no action required by current shareholders in connection with this change. The Company is also pleased to announce that it has secured DTC eligibility by The Depository Trust Company (“DTC”) for electronic settlement and transfer of its common shares in the United States.

“Our ticker symbol change is in line with our strategic transition into emerging field of robotic process automation and our plans to develop a proprietary bots operating platform”, said Bots, Inc CEO Paul Rosenberg. “We have made a decision to rebrand our company, develop and deliver our products to better meet the needs of companies looking to implement bots into their operations.”

The Company’s new website is available at www.bots.bz and shareholders can read about the Company’s strategy and ongoing advancements in technology on the company blog, which can be viewed at www.bots.bz/blog

About BOTS, Inc.

Headquartered in San Juan, Puerto Rico, BOTS, Inc. – publicly traded on the OTC Markets under the symbol (MCIG) and on Börse Stuttgart under ticker (M06.SG) – is a diversified company servicing the robotics needs of its customers. The Company is committed to drive the innovations needed to shape the future of robotic automation management through digital technology and decentralized blockchain solutions. Management is dedicated to the strong growth of Distributed Asset Technology and Robotic Process Automation (RPA)

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.bots.bz

 

Visit us on Facebook @ https://www.facebook.com/Bots.Bz/

Follow us on Twitter @Bots_bz

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at http://www.bots.bz.

Contact:

Paul Rosenberg

paul@bots.bz

0

JACKSONVILLE, FL, May 26, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BOTS, Inc. (OTCMARKETS: MCIG) (GERMAN EXCHANGE: M06.SG), emerging innovator of products, technologies, and services for the rapidly growing robotics industry – announced today the acquisition of D’BOT Technology Corp (“D’BOT”).

D’BOT has developed several cutting edge AI powered trading bot platforms (in Beta phase) and has an experienced team of developers with expertise in robotic automation processes and enterprise grade blockchain platforms to deliver advanced crypto and financial services with unprecedented security and transaction speeds.

Bots, Inc ($BOTStm ) plan is to leverage the technological platform powered by D’BOT in different industry segments in order to generate revenue by introducing a novel hybrid decentralized cryptocurrency exchange that has many innovative features such as its own unique DEX blockchain.

Market capitalization for all crypto coins currently stands at a quarter of a trillion dollars. Twenty-four-hour trade volume in the cryptocurrency market passed the $110 billion mark according to CoinMarketCap.com.

Decentralized exchanges are rapidly growing in popularity due to fewer regulations and being less susceptible to hacking. In 2019 total volume in USD was for this segment grew to 2.5 billion dollars.

“If you were worried about having your cryptocurrency stolen from a traditional centralized exchange, You were not alone.”-said Paul Rosenberg, Company’s CEO. “From Mt. Gox to Bitfinex and many other crypto exchanges, there has been too many well-publicized news stories around the world of exchanges being hacked and hundreds of millions of dollars’ worth of crypto being stolen along with personal information. We will offer completely new ways to trade digital currencies without keeping your coins on the servers of third-party exchanges but instead traded utilizing decentralized crypto exchanges known as being “DEX” powered but in our case, secured by bots.

A recent Forbes.com article https://www.forbes.com/sites/oluwaseunadeyanju/2020/04/28/why-bitcoin-exchanges-are-building-their-own-blockchain/amp/ discussed several new developments in the DEX industry, like “developing blockchain based crypto exchanges which will be able to grow their market share and operate more efficiently” and the fact that the world’s busiest crypto exchanges are betting on decentralized platforms to drive the growth of decentralized commercial applications, particularly toward institutional financial inclusion.

Management believes that in post-covid economy decentralization and more decentralized economies will emerge as being an indispensable addition to any industry.

About BOTS, Inc.

Headquartered in San Juan, Puerto Rico, BOTS, Inc. -publicly traded on the OTC Markets under the symbol (OTC:MCIG) and on Börse Stuttgart under ticker (M06.SG) – is a diversified company servicing the robotics needs of its customers. The Company is committed to drive the innovations needed to shape the future of robotic automation management through digital technology and decentralized blockchain solutions. Management is dedicated to the strong growth of Distributed Asset Technology and Robotic Process Automation (RPA)

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.bots.bz

 

Visit us on Facebook @ https://www.facebook.com/Bots.Bz/

 

Follow us on Twitter @Bots_bz

 

Forward-Looking Statements

 

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at http://www.bots.bz.

 

Contact:

 

Paul Rosenberg

 

paul@mciggroup.org

0

JACKSONVILLE, FL, March, 13, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development today announced execution of a Letter of Intent (LOI) reflecting the Company’s strategic partnership with NJ based, Kaplan Group d/b/a Medical Home Pharmacy (http://www.medicalhomepharmacy.com/,

https://www.youtube.com/watch?v=LWqRacr-ZRY).

Kaplan Group has an extensive history designing personalized, patient-centric programs enhancing health outcomes and experience, and has developed close relationships with hospitals and health systems, community physician practices, among other community referral sources.

Kaplan Group is known for referring hospitals and physicians to innovative research and program development, bringing personalized solutions with a strong track record of driving enhanced patient engagement, health outcomes and satisfaction scores.

Kaplan Group has cultivated patient trust and loyalty that is key to uninhibited patient engagement which will lead to early adoption of (cutting edge) health and wellness solutions. With over four decades of experience, Kaplan Group owns, and operates, state of the art pharmacies equipped with specialty dispensing, and compounding labs, robotic dispensing, and patient friendly packaging solutions.  

Whether servicing high risk, medically complex patients, or those with minimal needs, the approach is always to optimize the unique health and wellness potential for the individual.

Kaplan Group also brings strategic access to international markets, including a network of countries serviced by a centrally located Medical Tourism program.

Ahmet Ugur, an advisor for Kaplan Group states: “Kaplan Group is cultivating relationships with large employers, and labor unions, and will be applying their expertise at a population management level. They’re also exploring new opportunities in research and product development, supply chain management and clinical studies, to offer personalized, precision health and wellness solutions. Accordingly, larger markets will allow for leveraging of scalable, personalized technologies, and disruptive solutions, leading to mutually beneficial opportunities for both parties.”

Accordingly, Kaplan Group sees this aligning very strategically with MCIG’s interest in integrating health & wellness solutions, with access to larger populations.

Paul Rosenberg, MCIG’s Chief Executive Officer, said: “We are excited to partner exclusively with Kaplan Group. MCIG’s strategy is to build a strategic ecosystem of products and services to address the health and wellness multi-billion dollar market that Kaplan Group will sell, promote, and track the outcomes. Kaplan Group brings to the marketplace breakthrough products with cutting edge technologies, and services, this will provide huge opportunities that MCIG looks very much forward to being a part of.”

 

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

 

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

Contact:

mCig, Inc.

Paul Rosenberg

paul@mciggroup.org

0

JACKSONVILLE, FL, Feb. 04, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – mCig, Inc. (MCIG), a vertically integrated company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, today announced that its subsidiary (BRRX Clinical) will be launched on Monday, February 10, 2020.

Dale Hipes, CEO of BareRoots-Rx Inc., stated: “We believe the launch of the new site will be an opportunity to set our brand apart from the competition. The site will target individual participants, and it will be responsive to the identification of the members’ health – via the completion of health risk assessments, biometrics, and labs. Once the results are in, an individual will be able to choose various levels of monthly participation allowing them to work towards the goal of (lifestyle) improvements, and well being. The opportunity to craft products specific for the individual is the goal that will assist them in targeting their improvement. Our main objective has always been to assist people in living better, healthy lives.” 

Paul Rosenberg, CEO of mCig, stated: “I am confident that we are moving in the right direction by gearing our products toward individuals with specific goals in mind. Awareness is the first step in advancement and then taking the appropriate action, such as locating the necessary steps to live better. This is the best potential outcome we could hope for with our consumers. We are projecting considerable interest in our forthcoming website and our unique approach to target the healthcare industry.”

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

0

JACKSONVILLE, FL – (NewMediaWire) – January 27, 2020 – mCig, Inc. (MCIG), a vertically integrated company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics targeting the endocannabinoid system, today announced the business plan for the nutraceutical joint venture of the Company and Bare Roots, Inc.

BRRX Clinical will operate under two divisions, Consumer Products, and Health Care. The Consumer Products Division will operate much as most other CBD product companies, however, the emphasis will be on products with verifiable efficacy and prescribed dosages. As part of this strategy the company now has three products Registered with an FDA Institutional Review Board (IRB) in Clinical Trials. The first of these, a salve to alleviate the pain from Shingles outbreaks, was announced recently and will be available through a network of independent compounding pharmacies along with two other products also in trials. One of them, a regimen consisting of three packets of a CBD compound ingested daily is targeted at treating liver cirrhosis and fibrosis and is expected to retail for about $400 to $600/month. The last of the three products is a balm targeted at relieving the inflammation from Herpes.

Starting in February, the company will launch its Health Care Division. The core product for this division is a software platform developed over the past 15 years to detect an individual’s predisposition to certain diseases up to three years before symptoms reveal themselves. The platform is a GE/Intel certified program that has been in use for several years. It analyzes blood work, lab results, and genetic information to develop an individual profile that can be used to target that person for certain interventions like a change in diet, supplements or specific exercises.

The launch will start with the BRRX Clinical Subscription Service, a set of services complementing the software platform that will utilize participating clinics and doctor networks to drive consumers to get healthcare before their symptoms require more drastic medical intervention. The plan is for this to be a product marketed to employers, carriers, Physician Networks, and individuals.

According to Dale Hipes, CEO of BRRX Clinical, “We want the focus to be on a holistic approach customized to each client. People can start with a base plan which will have a three-month minimum subscription, and which will develop a blood, genetic, and nutritional profile for each individual. The premium plan is expected to include a week of organic meal service based on an individual’s nutrition plan developed from the initial testing. Members will also have free access to fitness centers, telemedicine services, daily nutraceutical supplements and monthly blood tests in consultation with their physician to identify any bodily changes which could alter their health profile. Additionally, the plan will include catastrophic health insurance and Dental and Vision coverage with required annual checkups.”

The company expects to market the plan through insurance brokers and is conservatively projecting $1 to $2 million in revenue from BRRX Clinical during its first year of operation. This is in addition to the $1.3 million in CBD product orders announced on January 17. New revenue is also expected from the independent pharmacy network as they conduct the aforementioned clinical trials, and from an anticipated CBD cosmetics line to be released later in the year.

Paul Rosenberg, CEO of mCig, Inc., stated: “The clinical subscription service, once launched, could potentially create a significant new revenue stream for mCig. It puts mCig/Bare Roots into a category nothing like any existing CBD company or insurance services provider.”

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.govand on the Company’s website at www.mciggroup.com.

 

Contact:

mCig, Inc.

Paul Rosenberg

paul@mciggroup.org

0

JACKSONVILLE, FL – (NewMediaWire) – January 23, 2020 – mCig, Inc. (OTCQB:MCIG), vertically integrated company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics targeting the endocannabinoid system today announced that the nutraceutical joint venture of the Company and BRRx Clinical Inc. is set to move forward with an LOI to supply a national independent compounding pharmacy network. BRRX Clinical will begin releasing the CBD enhanced medical foods/topical applications that are in FDA trials. The products are registered with the International Review Board. The first of these offerings will be for the treatment of shingles. The salve will be valuable not only for protocols established but for addressing the pain that accompanies this diagnosis as well. The Researcher, developer, and advisors have hit the mark in this delivery for relief and a trajectory for reversal of this diagnosis.

Dale Hipes, CEO of BRRX Clinical, states, “We are following a very strategic and well-crafted plan by our senior management team. We are looking forward to many great opportunities to affect change, be the standard for the new Healthcare modalities that Hemp-Derived treatments and capabilities bring to the marketplace.”

Paul Rosenberg, CEO of mCig, Inc., added, “Dale completely changed my view on the whole cannabis industry and the steps the Company should take in order to stay ahead of its competitors. In a few weeks, we are going to introduce our revolutionary BRRx Clinical web portal, which will allow the Company to offer some unique products that will change the lives of millions of people.”

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.

Visit us on Facebook @ https://www.facebook.com/mCigInc/

Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

 

Contact: 

mCig, Inc.

Paul Rosenberg

paul@mciggroup.org

0

JACKSONVILLE, FL – (NewMediaWire) – January 21, 2020 – mCig, Inc. (OTCQB:MCIG), a vertically integrated company focused on the development and commercialization of over the counter, science-driven, botanical nutrigenetics, that target the endocannabinoid system, announces today that the company’s subsidiary, BareRoots Rx, is launching the Co-branding deal with the Tucson Sugar Skulls of the IFL as their exclusive CBD sports partner.

Dale Hipes, CEO of BareRoots, says: “This is a great opportunity for BareRoots to help bring CBD to households in the Arizona region and Nationally throughout the US. The Tucson SugarSkulls (an IFL Franchise) brings a captive audience of more than 3.5 million fans nationally, and over 900,000 fans native to the Tucson area. BareRoots Rx,  and the Tucson SugarSkulls IFL Franchise will be launching for the 2020 season a co-branded CBD line of products to sell along-side other SugarSkulls products and gear.”

Paul Rosenberg, CEO of mCig, Inc., continued: “The rise in popularity for CBD products can be attributed to the consumer’s quest for natural-based health and wellness solutions to treat perpetual ailments, including those derived from athletics such as inflammation, and pain. The hemp-derived CBD market has been estimated to reach US$22 billion by 2022 and the impact of cannabinoids on health, and treatment has not gone unnoticed in professional sports.

“We will leverage the Scottsdale Facility to manufacture and distribute a suite of athlete-focused, CBD performance products, including:

• CBD Therapeutic sleep tinctures;

• CBD Pain tinctures;

• CBD-infused Protein drinks

• CBD-infused balms for optimal topical absorption.” 

MCIG/BareRoots Rx will be having a grand opening of their new facility, located at: 9332 N 95th Way St. B109, Scottsdale, AZ, on January 30, 2020, between 4-7 pm.

Clients, staff, and partners are all welcome to come.

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Visit us on Facebook @ https://www.facebook.com/mCigInc/Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health, and well being, as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.govand on the Company’s website at www.mciggroup.com.

Contact:

mCig, Inc.

Paul Rosenberg

paul@mciggroup.org

0

JACKSONVILLE, FL – (NewMediaWire) – January 17, 2020 – mCig, Inc. (OTCQB:MCIG), vertically integrated company focused on the development and commercialization of over the counter, science-driven, botanical nutrigenetics that target the endocannabinoid system, today announced that the company’s CBD consumer division has agreements to commence this quarter.

MCIG Inc. subsidiary, BareRoots Rx Inc., the consumer products division, has entered into an agreement to distribute 10,000 monthly boxes of the COMPANY’S PROPRIETARY CBD-BASED PRODUCTS to select tribal communities. The company anticipates revenue of approximately $1.1 Mil in its first year of operation under the agreement. It also has entered into a white labeling agreement with cannabis company to supply approximately $200,000 of CBD derivative products.

“This is an important milestone for company in securing new contractual revenue,” noted Paul Rosenberg, President and CEO, MCIG Inc. “This is the first of what we believe will be many derivative product sales and manufacturing agreements for our new facility in Scottsdale, Arizona.”

About MCIG Group

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.

The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com. Visit us on Facebook @ https://www.facebook.com/mCigInc/ Follow us on Twitter @mcigInc

About BareRoots Rx Inc.

The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also deliver high-quality consumer and OTC THC-free CBD products that promote overall health, and well being, as well as state-of-the-art testing and analytics capabilities to our customers.

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.

Contact: 

mCig, Inc. 

Paul Rosenberg 

paul@mciggroup.org

0